![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
ELECTRON: All-Oral Sofosbuvir-Based 12-Week Regimens for the Treatment of Chronic HCV GT 1 Infection
|
|
|
Reported by Jules Levin
Asian Pacific Association for the Study of the Liver 2013, Singapore
Edward J. Gane1, Catherine A. Stedman2, Robert H. Hyland3, Xiao Ding3, Phillip S. Pang3, Evguenia S. Svarovskaia3, William T. Symonds3, John G. McHutchison3
1Auckland Clinical Studies, Auckland, New Zealand; 2Christchurch Clinical Studies Trust, Christchurch, New Zealand; 3Gilead Sciences, Inc., Foster City, CA, USA
![APASL1.gif](../images/062513/062513-7/APASL1.gif)
![APASL2.gif](../images/062513/062513-7/APASL2.gif)
![APASL3.gif](../images/062513/062513-7/APASL3.gif)
![APASL4.gif](../images/062513/062513-7/APASL4.gif)
![APASL5.gif](../images/062513/062513-7/APASL5.gif)
![APASL6.gif](../images/062513/062513-7/APASL6.gif)
![APASL7.gif](../images/062513/062513-7/APASL7.gif)
![APASL8.gif](../images/062513/062513-7/APASL8.gif)
![APASL9.gif](../images/062513/062513-7/APASL9.gif)
![APASL10.gif](../images/062513/062513-7/APASL10.gif)
![APASL11.gif](../images/062513/062513-7/APASL11.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|